tradingkey.logo

908 Devices Inc.

MASS

6.590USD

+0.170+2.65%
Horarios del mercado ETCotizaciones retrasadas 15 min
235.52MCap. mercado
PérdidaP/E TTM

908 Devices Inc.

6.590

+0.170+2.65%
Más Datos de 908 Devices Inc. Compañía
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
Información de la empresa
Símbolo de cotizaciónMASS
Nombre de la empresa908 Devices Inc
Fecha de salida a bolsaDec 18, 2020
Director ejecutivoDr. Kevin J. Knopp, Ph.D.
Número de empleados246
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 18
Dirección645 Summer Street
CiudadBOSTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal02210
Teléfono19787294478
Sitio Webhttps://908devices.com/
Símbolo de cotizaciónMASS
Fecha de salida a bolsaDec 18, 2020
Director ejecutivoDr. Kevin J. Knopp, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Jon Frattaroli
Jon Frattaroli
Vice President - Strategy
Vice President - Strategy
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Barbara Russo
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
--
--
Mr. Jeffrey P. (Jeff) George
Mr. Jeffrey P. (Jeff) George
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Device sales revenue
7.41M
62.93%
Consumables and service revenue
4.30M
36.54%
License and contract revenue
63.00K
0.53%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
7.01M
59.54%
Europe,Middle East & Africa
4.45M
37.82%
Asia Pacific
181.00K
1.54%
Americas other
130.00K
1.10%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Device sales revenue
7.41M
62.93%
Consumables and service revenue
4.30M
36.54%
License and contract revenue
63.00K
0.53%
Estadísticas de accionistas
Actualizado: vie., 13 de jun
Actualizado: vie., 13 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
ARCH Venture Partners
15.96%
AWM Investment Company, Inc.
14.50%
ARK Investment Management LLC
7.38%
First Light Asset Management, LLC
4.74%
BlackRock Institutional Trust Company, N.A.
4.19%
Other
53.22%
Accionistas
Accionistas
Proporción
ARCH Venture Partners
15.96%
AWM Investment Company, Inc.
14.50%
ARK Investment Management LLC
7.38%
First Light Asset Management, LLC
4.74%
BlackRock Institutional Trust Company, N.A.
4.19%
Other
53.22%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
30.75%
Investment Advisor
23.79%
Venture Capital
16.08%
Individual Investor
8.44%
Hedge Fund
2.10%
Research Firm
1.28%
Bank and Trust
0.09%
Pension Fund
0.05%
Other
17.43%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
226
29.27M
81.62%
-3.83M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
2023Q3
261
30.10M
93.52%
-5.15M
2023Q2
268
30.29M
94.48%
-6.54M
2023Q1
275
31.04M
97.19%
-6.89M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
ARCH Venture Partners
5.73M
15.96%
--
--
Apr 17, 2025
AWM Investment Company, Inc.
5.20M
14.5%
--
--
Apr 17, 2025
ARK Investment Management LLC
2.90M
8.08%
+110.78K
+3.97%
Mar 31, 2025
First Light Asset Management, LLC
1.70M
4.74%
+1.70M
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.50M
4.19%
-90.70K
-5.70%
Mar 31, 2025
The Vanguard Group, Inc.
1.36M
3.8%
+37.64K
+2.84%
Mar 31, 2025
Knopp (Kevin J)
1.26M
3.52%
+30.00K
+2.43%
May 15, 2025
Brown (Christopher D)
962.12K
2.68%
--
--
Apr 17, 2025
Geode Capital Management, L.L.C.
589.84K
1.64%
+8.54K
+1.47%
Mar 31, 2025
Tao Capital Management LP
568.98K
1.59%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Genomic Revolution ETF
1.81%
SPDR S&P Kensho Future Security ETF
1.05%
SPDR S&P Kensho New Economies Composite ETF
0.53%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
Ver más
ARK Genomic Revolution ETF
Proporción1.81%
SPDR S&P Kensho Future Security ETF
Proporción1.05%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.53%
iShares Micro-Cap ETF
Proporción0.04%
Avantis US Small Cap Equity ETF
Proporción0.02%
Proshares Ultra Russell 2000
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI